New Biannual Anti-HIV Injection to Launch by 2027
Two Indian generic drugmakers, Hetero and Dr Reddy’s, will receive funding from the Gates Foundation and Unitaid, respectively, to manufacture ...
Two Indian generic drugmakers, Hetero and Dr Reddy’s, will receive funding from the Gates Foundation and Unitaid, respectively, to manufacture ...
The health department plans to roll out the anti-HIV jab lenacapavir, administered biannually, across over 300 government health districts with ...
South Africa has secured over $29 million from the Global Fund to purchase lenacapavir, a biannual anti-HIV injection, which research ...
A modelling study suggests that the lenacapavir anti-HIV jab could potentially end Aids in South Africa by 2032 if between ...
Copyright © 2025 News Wave
News Wave is not responsible for the content of external sites.
Copyright © 2025 News Wave
News Wave is not responsible for the content of external sites.